These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

584 related items for PubMed ID: 21900880

  • 1. Cysteamine therapy delays the progression of nephropathic cystinosis in late adolescents and adults.
    Brodin-Sartorius A, Tête MJ, Niaudet P, Antignac C, Guest G, Ottolenghi C, Charbit M, Moyse D, Legendre C, Lesavre P, Cochat P, Servais A.
    Kidney Int; 2012 Jan; 81(2):179-89. PubMed ID: 21900880
    [Abstract] [Full Text] [Related]

  • 2. Nephropathic cystinosis in adults: natural history and effects of oral cysteamine therapy.
    Gahl WA, Balog JZ, Kleta R.
    Ann Intern Med; 2007 Aug 21; 147(4):242-50. PubMed ID: 17709758
    [Abstract] [Full Text] [Related]

  • 3. Controversies and research agenda in nephropathic cystinosis: conclusions from a "Kidney Disease: Improving Global Outcomes" (KDIGO) Controversies Conference.
    Langman CB, Barshop BA, Deschênes G, Emma F, Goodyer P, Lipkin G, Midgley JP, Ottolenghi C, Servais A, Soliman NA, Thoene JG, Levtchenko EN, Conference Participants.
    Kidney Int; 2016 Jun 21; 89(6):1192-203. PubMed ID: 27181776
    [Abstract] [Full Text] [Related]

  • 4. Population pharmacokinetics and pharmacodynamics of cysteamine in nephropathic cystinosis patients.
    Bouazza N, Tréluyer JM, Ottolenghi C, Urien S, Deschenes G, Ricquier D, Niaudet P, Chadefaux-Vekemans B.
    Orphanet J Rare Dis; 2011 Dec 23; 6():86. PubMed ID: 22195601
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Long-term outcome of nephropathic cystinosis: a 20-year single-center experience.
    Greco M, Brugnara M, Zaffanello M, Taranta A, Pastore A, Emma F.
    Pediatr Nephrol; 2010 Dec 23; 25(12):2459-67. PubMed ID: 20803298
    [Abstract] [Full Text] [Related]

  • 8. Outcome of infantile nephropathic cystinosis depends on early intervention, not genotype: A multicenter sibling cohort study.
    Veys K, Zadora W, Hohenfellner K, Bockenhauer D, Janssen MCH, Niaudet P, Servais A, Topaloglu R, Besouw M, Novo R, Haffner D, Kanzelmeyer N, Pape L, Wühl E, Harms E, Awan A, Sikora P, Ariceta G, van den Heuvel B, Levtchenko E.
    J Inherit Metab Dis; 2023 Jan 23; 46(1):43-54. PubMed ID: 36117148
    [Abstract] [Full Text] [Related]

  • 9. Cystinosis: renal glomerular and renal tubular function in relation to compliance with cystine-depleting therapy.
    Nesterova G, Williams C, Bernardini I, Gahl WA.
    Pediatr Nephrol; 2015 Jun 23; 30(6):945-51. PubMed ID: 25526929
    [Abstract] [Full Text] [Related]

  • 10. [Cystinosis in adults: A systemic disease].
    Servais A, Goizet C, Bertholet-Thomas A, Decramer S, Llanas B, Choukroun G, Novo R.
    Nephrol Ther; 2015 Jun 23; 11(3):152-9. PubMed ID: 25769364
    [Abstract] [Full Text] [Related]

  • 11. Follow-up and treatment of renal transplantation with nephropathic cystinosis in central Taiwan.
    Chuang YW, Wen MC, Wu MJ, Shu KH, Cheng CH, Yu TM, Huang ST, Chen CH.
    Transplant Proc; 2012 Jan 23; 44(1):80-2. PubMed ID: 22310585
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Effects of early cysteamine therapy on thyroid function and growth in nephropathic cystinosis.
    Kimonis VE, Troendle J, Rose SR, Yang ML, Markello TC, Gahl WA.
    J Clin Endocrinol Metab; 1995 Nov 23; 80(11):3257-61. PubMed ID: 7593434
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Switching from immediate- to extended-release cysteamine in nephropathic cystinosis patients: a retrospective real-life single-center study.
    Ahlenstiel-Grunow T, Kanzelmeyer NK, Froede K, Kreuzer M, Drube J, Lerch C, Pape L.
    Pediatr Nephrol; 2017 Jan 23; 32(1):91-97. PubMed ID: 27350621
    [Abstract] [Full Text] [Related]

  • 16. Diagnostic challenge in a patient with nephropathic juvenile cystinosis: a case report.
    Higashi S, Matsunoshita N, Otani M, Tokuhiro E, Nozu K, Ito S.
    BMC Nephrol; 2017 Sep 26; 18(1):300. PubMed ID: 28950840
    [Abstract] [Full Text] [Related]

  • 17. Follow-up and treatment of adults with cystinosis in the Netherlands.
    Geelen JM, Monnens LA, Levtchenko EN.
    Nephrol Dial Transplant; 2002 Oct 26; 17(10):1766-70. PubMed ID: 12270982
    [Abstract] [Full Text] [Related]

  • 18. Early oral cysteamine therapy for nephropathic cystinosis.
    Gahl WA.
    Eur J Pediatr; 2003 Dec 26; 162 Suppl 1():S38-41. PubMed ID: 14610675
    [Abstract] [Full Text] [Related]

  • 19. Nephropathic cystinosis: late complications of a multisystemic disease.
    Nesterova G, Gahl W.
    Pediatr Nephrol; 2008 Jun 26; 23(6):863-78. PubMed ID: 18008091
    [Abstract] [Full Text] [Related]

  • 20. Pharmacological treatment of nephropathic cystinosis with cysteamine.
    Kleta R, Gahl WA.
    Expert Opin Pharmacother; 2004 Nov 26; 5(11):2255-62. PubMed ID: 15500372
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 30.